Research & Insights
December 08, 2023
The Overlooked Building Blocks of the Energy Transition
In this piece, Lazard Asset Management argues that exposure to the energy transition may be best achieved by owning the equities of the materials producers that are poised to benefit from it over time.
Can the Obesity Drug Market Meet High Expectations?
Lazard Asset Management discusses recent developments in the obesity drug segment, attempts to rationalize market expectations, and explain the implications on drugmakers and medical device companies.
Small Caps Poised to Make Big Moves?
Lazard Chief Market Strategist Ronald Temple discusses the outlook for U.S. small-cap stocks.
